Skip to main content
S&P 5007,811.54+0.59%DOW51,654.95+0.83%NASDAQ27,366.17+0.64%BTC$82,516.00+0.84%ETH$2,488.45+0.36%GOLD$4,220.30+1.52%OIL$91.66+0.19%
Smart Investors Daily
SID Premium
CO

NASDAQ · COCHW

Envoy Medical, Inc.

Healthcare · Medical - Devices

$0.04

Up+$0.00 (+8.40%)

Updated Oct 10, 2026, 4:47 PM

SID Score

3.1/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
777.92K
P/E ratio
-0.75
Dividend yield
0.00%
52-week range
$0.02 – $0.10
Volume
31.41K
Avg. volume
38.74K

Price performance · COCHW

COCHW price history

1M range · 12 trading sessions · Daily adjusted prices

Prices through Oct 8, 2026

COCHW closed at $0.04 after 12 trading sessions, down 14.89% for the selected period.

Last close
$0.04
Period change
-14.89%
Period low
$0.03
Period high
$0.06
Daily close
View OHLC price history
COCHW OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 8, 2026$0.0397$0.04$0.0329$0.0431.41K
Oct 2, 2026$0.0329$0.0427$0.0329$0.042711.99K
Oct 1, 2026$0.0303$0.0303$0.029$0.03133.38K
Sep 30, 2026$0.0315$0.0316$0.0303$0.031517.43K
Sep 29, 2026$0.0315$0.04$0.0315$0.04124.81K
Sep 24, 2026$0.0317$0.0317$0.0317$0.0317100
Sep 22, 2026$0.033$0.046$0.03$0.030270.3K
Sep 18, 2026$0.041$0.0455$0.0301$0.030147.01K
Sep 16, 2026$0.0539$0.0539$0.0516$0.052910.95K
Sep 15, 2026$0.041$0.056$0.041$0.055936.52K
Sep 14, 2026$0.058$0.058$0.041$0.0411.97K
Sep 11, 2026$0.04$0.0477$0.04$0.04716.59K

Latest COCHW news

The latest Smart Investors Daily articles mentioning COCHW.

Stock researchCompany · Overview

COCHW research

Overview

Company profile and research snapshot.

Company profile

Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 22, 2026

Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio

Canadian and Hong Kong Patents Continue to Strengthen Intellectual Property Protection Across Envoy Medical's Fully Implanted Hearing PlatformWhite Bear Lake, Minnesota--(Newsfile Corp. - September 22, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced the grant of two additional international patents, expanding its global intellectual property portfolio to 97 patents, consisting of

Yahoo · Sep 2, 2026

Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th

White Bear Lake, Minnesota--(Newsfile Corp. - September 2, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced that Brent Lucas, Envoy Medical's Chief Executive Officer, will present at the H.C. Wainwright 28th Annual Global Investment Conference, on September 14-16, 2026 at the Lotte New York Palace Hotel in New York City.H.C. Wainwright Conference Presentation...

Yahoo · Jun 25, 2026

Envoy Medical Terminates At-the-Market (ATM) Equity Facility

Termination Reflects Company's Confidence in Current Capital PositionWhite Bear Lake, Minnesota--(Newsfile Corp. - June 25, 2026) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company pioneering fully implanted hearing solutions, today announced that it has formally terminated its at-the-market equity facility (the "ATM Facility").The ATM Facility, under which the Company was previously authorized to offer and sell up to $15 million worth of shares of its common stock

Yahoo · Feb 24, 2026

Envoy Medical Regains Compliance with Nasdaq Listing Requirement

White Bear Lake, Minnesota--(Newsfile Corp. - February 24, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that it has received written notification from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has evidenced compliance with Nasdaq Listing Rule 5550(b)(2) through the alternatives permitted under Listing Rule 5550(b).As previously disclosed, the Company..

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By